Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome.

Linglart A, Cabrol S, Berlier P, Stuckens C, Wagner K, de Kerdanet M, Limoni C, Carel JC, Chaussain JL; French Collaborative Young Turner Study Group.

Eur J Endocrinol. 2011 Jun;164(6):891-7. doi: 10.1530/EJE-10-1048. Epub 2011 Mar 11.

PMID:
21398400
2.

Long-acting lanreotide in adolescent girls with constitutional tall stature.

Carel JC, Blumberg J, Bougeard-Julien M, Rochiccioli P, Chaussain JL, Tauber M; Lanreotide in Tall Stature Study Group.

Horm Res. 2009;71(4):228-36. doi: 10.1159/000201112. Epub 2009 Mar 4.

PMID:
19258715
3.

Self-esteem and social adjustment in young women with Turner syndrome--influence of pubertal management and sexuality: population-based cohort study.

Carel JC, Elie C, Ecosse E, Tauber M, Léger J, Cabrol S, Nicolino M, Brauner R, Chaussain JL, Coste J.

J Clin Endocrinol Metab. 2006 Aug;91(8):2972-9. Epub 2006 May 23.

PMID:
16720662
4.

Puberty in subjects with complete androgen insensitivity syndrome.

Papadimitriou DT, Linglart A, Morel Y, Chaussain JL.

Horm Res. 2006;65(3):126-31. Epub 2006 Feb 16.

PMID:
16491011
5.

Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.

Soriano-Guillen L, Coste J, Ecosse E, Léger J, Tauber M, Cabrol S, Nicolino M, Brauner R, Chaussain JL, Carel JC.

J Clin Endocrinol Metab. 2005 Sep;90(9):5197-204. Epub 2005 Jul 5.

PMID:
15998771
6.

[Andrew Schally, discover of GnRH].

Bouchard P, Chaussain JL, Deheunin L, Lahlou N, Roger M.

Rev Prat. 2005;Spec. No:3. French. No abstract available.

PMID:
15822861
7.

Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.

Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.

J Pediatr. 2005 Jan;146(1):45-53.

PMID:
15644821
8.

Quality of life determinants in young women with turner's syndrome after growth hormone treatment: results of the StaTur population-based cohort study.

Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Léger J, Nicolino M, Brauner R, Chaussain JL, Coste J.

J Clin Endocrinol Metab. 2005 Apr;90(4):1992-7. Epub 2005 Jan 11.

PMID:
15644402
9.

Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty.

Soriano-Guillén L, Lahlou N, Chauvet G, Roger M, Chaussain JL, Carel JC.

J Clin Endocrinol Metab. 2005 Jan;90(1):147-51. Epub 2004 Nov 2.

PMID:
15522928
10.

Precocious puberty and statural growth.

Carel JC, Lahlou N, Roger M, Chaussain JL.

Hum Reprod Update. 2004 Mar-Apr;10(2):135-47. Review.

PMID:
15073143
11.

Treatment of growth hormone deficiency in very young children.

Carel JC, Huet F, Chaussain JL.

Horm Res. 2003;60(Suppl 1):10-7. Review.

12.

Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.

de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10972-6. Epub 2003 Aug 27.

13.

[A peculiar form of neonatal adrenal insufficiency: the IMAGe association. Two new cases].

Ferey S, Merzoug V, Linglart A, Chaussain JL, Kalifa G.

J Radiol. 2003 Mar;84(3):323-5. French.

PMID:
12736593
14.
15.

[Critical analysis of treatments with growth hormones in children].

Chaussain JL.

Bull Acad Natl Med. 2002;186(7):1211-6; discussion 1216-9. French.

PMID:
12669662
16.

Adrenoleukodystrophy: the most frequent genetic cause of Addison's disease.

Aubourg P, Chaussain JL.

Horm Res. 2003;59 Suppl 1:104-5. No abstract available.

PMID:
12638520
18.

Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg).

Carel JC, Lahlou N, Jaramillo O, Montauban V, Teinturier C, Colle M, Lucas C, Chaussain JL.

J Clin Endocrinol Metab. 2002 Sep;87(9):4111-6.

PMID:
12213857
19.

Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.

Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W.

Horm Res. 2002;58(1):1-7.

PMID:
12169774
20.
21.

[When and how to treat a central precocious puberty?].

Carel JC, Linglart A, Roger M, Lalhou N, Chaussain JL.

Arch Pediatr. 2002 May;9 Suppl 2:237s-239s. Review. French. No abstract available.

PMID:
12108279
22.

Amplitude of pubertal growth in short stature children with intrauterine growth retardation.

Lienhardt A, Carel JC, Preux PM, Coutant R, Chaussain JL.

Horm Res. 2002;57 Suppl 2:88-94.

PMID:
12065935
23.

IMAGe association: additional clinical features and evidence for recessive autosomal inheritance.

Lienhardt A, Mas JC, Kalifa G, Chaussain JL, Tauber M.

Horm Res. 2002;57 Suppl 2:71-8.

PMID:
12065932
24.

Aetiological diagnosis of male sex ambiguity: a collaborative study.

Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, Mowszowicz I, Jaubert F, Fellous M, Chaussain JL, Chatelain P, David M, Nihoul-Fékété C, Forest MG, Josso N.

Eur J Pediatr. 2002 Jan;161(1):49-59. Review.

PMID:
11808880
25.

Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene.

Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, Morel Y, Chaussain JL.

J Clin Endocrinol Metab. 2002 Jan;87(1):29-32.

PMID:
11788616
26.

Growth abnormalities associated with adrenal disorders and their management.

Savage MO, Lebrethon MC, Blair JC, Ho JT, Johnston LB, Lienhardt A, Clark AJ, Chaussain JL.

Horm Res. 2001;56 Suppl 1:19-23. Review.

PMID:
11786680
27.

PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezène F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, Jaquet P, Enjalbert A, Brue T.

J Clin Endocrinol Metab. 2001 Sep;86(9):4529-35.

PMID:
11549703
28.
29.

[Use of initial high doses of growth hormone in the treatment of short children with deficient secretion of the hormone].

Chaussain JL, Carel JC.

Acta Biomed Ateneo Parmense. 2000;71(3-4):107-10. Italian. No abstract available.

PMID:
11424605
30.

[Use of high doses of growth hormone in children with short body height secondary to an deficient secretion of this hormone].

Chaussain JL.

Bull Acad Natl Med. 2000;184(5):1061-6; discussion 1066-8. French.

PMID:
11077725
31.

Mutant WD-repeat protein in triple-A syndrome.

Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C, Bégeot M, Naville D, Nicolino M, Chaussain JL, Weissenbach J, Munnich A, Lyonnet S.

Nat Genet. 2000 Nov;26(3):332-5.

PMID:
11062474
32.

Long-term follow-up evaluation of magnetic resonance imaging in the prognosis of permanent GH deficiency.

Bozzola M, Mengarda F, Sartirana P, Tatò L, Chaussain JL.

Eur J Endocrinol. 2000 Oct;143(4):493-6.

PMID:
11022195
33.

Pharmacological testing for the diagnosis of growth hormone deficiency.

Carel JC, Coste J, Gendrel C, Chaussain JL.

Growth Horm IGF Res. 1998 Feb;8 Suppl A:1-8.

PMID:
10993583
34.

Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics.

Lahlou N, Carel JC, Chaussain JL, Roger M.

J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:723-37. Review.

PMID:
10969915
35.

Linkage disequilibrium in inbred North African families allows fine genetic and physical mapping of triple A syndrome.

Hadj-Rabia S, Salomon R, Pelet A, Penet C, Rotschild A, de Laët MH, Chaouachi B, Hannachi R, Bakiri F, Brauner R, Chaussain JL, Munnich A, Lyonnet S.

Eur J Hum Genet. 2000 Aug;8(8):613-20.

36.

Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.

de Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Löfström A, Jonsson B, Rosenfeld RG.

J Clin Endocrinol Metab. 2000 Aug;85(8):2816-21.

PMID:
10946888
37.

Gonadotropin treatment of hypogonadotropic hypogonadal adolescents.

Bouvattier C, Tauber M, Jouret B, Chaussain JL, Rochiccioli P.

J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:339-44.

PMID:
10698599
38.

New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.

Moisan AM, Ricketts ML, Tardy V, Desrochers M, Mébarki F, Chaussain JL, Cabrol S, Raux-Demay MC, Forest MG, Sippell WG, Peter M, Morel Y, Simard J.

J Clin Endocrinol Metab. 1999 Dec;84(12):4410-25.

PMID:
10599696
39.

Gonadotropin releasing hormone agonist treatment for central precocious puberty.

Carel JC, Chaussain JL.

Horm Res. 1999;51 Suppl 3:64-9. Review.

PMID:
10592446
40.

Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency.

Carel JC, Le Stunff C, Condamine L, Mallet E, Chaussain JL, Adnot P, Garabédian M, Bougnères P.

J Clin Endocrinol Metab. 1999 Nov;84(11):4127-31.

PMID:
10566660
41.

Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study.

Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougnères PF.

J Clin Endocrinol Metab. 1999 Oct;84(10):3575-8.

PMID:
10522998
42.

Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.

Huillard d'Aignaux J, Costagliola D, Maccario J, Billette de Villemeur T, Brandel JP, Deslys JP, Hauw JJ, Chaussain JL, Agid Y, Dormont D, Alpérovitch A.

Neurology. 1999 Oct 12;53(6):1197-201.

PMID:
10522872
43.

45,X/46,XY mosaicism: report of 27 cases.

Telvi L, Lebbar A, Del Pino O, Barbet JP, Chaussain JL.

Pediatrics. 1999 Aug;104(2 Pt 1):304-8.

PMID:
10429013
44.
45.

Long-term results of GH therapy in GH-deficient children treated before 1 year of age.

Huet F, Carel JC, Nivelon JL, Chaussain JL.

Eur J Endocrinol. 1999 Jan;140(1):29-34.

PMID:
10037248
47.

Clinical and prognostic aspects of adrenocortical neoplasms in childhood.

Teinturier C, Pauchard MS, Brugières L, Landais P, Chaussain JL, Bougnères PF.

Med Pediatr Oncol. 1999 Feb;32(2):106-11.

PMID:
9950198
48.

[Growth hormone treatment of children with short stature secondary to intrauterine growth retardation].

Chaussain JL, Carel JC.

Arch Pediatr. 1998;5 Suppl 4:345S-347S. French.

PMID:
9853081
49.

[Catch-up growth in growth hormone deficit children treated with GH since the first year of life].

Huet F, Carel JC, Nivelon JL, Chaussain JL.

Arch Pediatr. 1998;5 Suppl 4:318S-321S. French.

PMID:
9853076
50.

Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency.

Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, Cacheux V, Hafez M, Salah N, Chaussain JL, Goossens M, Bougnères P, Amselem S.

FEBS Lett. 1998 Oct 23;437(3):216-20.

Supplemental Content

Loading ...
Support Center